NRX Pharmaceuticals (NRXP) Net Cash Flow Growth (5y) (2022 - 2026)
NRX Pharmaceuticals (NRXP) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | NRX Pharmaceuticals | 125.08 Mn | 118.38 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.95% |
| Dec 31, 2025 | 15.15% |
| Sep 30, 2025 | 62.79% |
| Jun 30, 2025 | -16.01% |
| Mar 31, 2025 | 119.39% |
| Dec 31, 2024 | -0.88% |
| Sep 30, 2024 | -27.02% |
| Jun 30, 2024 | 323.83% |
| Mar 31, 2024 | -223.40% |
| Sep 30, 2023 | -74.75% |
| Jun 30, 2023 | -37.76% |
| Mar 31, 2023 | -81.09% |
| Dec 31, 2022 | 32.06% |